Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan

NCT00212693 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: ONO-2506PO

Sponsor

Ono Pharmaceutical Co., Ltd.